EpiCast Report: Bladder Cancer- Epidemiology Forecast to 2025 this report forecast that by 2025, the 7MM are expected to have 289,623 diagnosed incident cases of bladder cancer, representing a 23.5 % increase from the number of incident cases in 2015( 234,581 incident cases). In 2015, the 7MM had 873,493 five-year diagnosed prevalent cases of bladder cancer and epidemiologists forecast that by 2025, this number will grow to 1,094,707 five-year diagnosed prevalent cases at an Annual Growth Rate( AGR) of 2.53 %.
Complete report on EpiCast Report: Bladder Cancer- Epidemiology Forecast to 2025 spread across 40 pages is available at http:// www. reportsnreports. com / reports / 807780-epicast-report-bladdercancer-epidemiology-forecast-to-2025. html
This forecast is supported by at least 10 years of historical data obtained from country-specific studies published by the World Health Organization ' s( WHO) International Agency for Research on Cancer( IARC), the National Cancer Institute ' s( NCI) Surveillance, Epidemiology, and End Results( SEER) program, the European Cancer Registry ' s fifth database registry( EUROCARE-5), the Center for Cancer Control and Information Services, National Cancer Center( CCCIS, NCC) in Japan, as well as country-specific cancer registries. Another major strength of this analysis is that GlobalData epidemiologists were able to forecast incident cases of bladder cancer in the 7MM by age, sex, and stage at diagnosis. Furthermore, the forecast methodology was consistent across all markets, thereby allowing for a meaningful global comparison.
Key Points Covered In This Reports:
� � � � �
�
5EU, Relative Survival of Bladder Cancer(%), Men and Women 7MM, Sources of Bladder Cancer Incidence Data 7MM, Sources of Bladder Cancer Stage at Diagnosis Data 7MM, Sources of Bladder Cancer Relative Survival Data 7MM, Diagnosed Incident Cases of Bladder Cancer, Ages? 15 Years, Both Sexes, N, Select Years 2015-2025 7MM, Age-Specific Diagnosed Incident Cases of Bladder Cancer, Ages? 15 Years, Both Sexes, N( Row %), 2015 � 7MM, Sex-Specific Diagnosed Incident Cases of Bladder Cancer, Ages? 15 Years, N( Row %), 2015 � 7MM, Incident Cases of Bladder Cancer by Stage at Diagnosis, Ages? 15 Years, Men and Women,
N( Row %), 2015 � 7MM, Five-Year Diagnosed Prevalent Cases of Bladder Cancer, Ages? 15 Years, Both Sexes, N,
Select Years 2015-2025
Request Sample Report http:// www. reportsnreports. com / contacts / requestsample. aspx? name = 807780
Key Highlights
The Bladder Cancer EpiCast Report provides an overview of the risk factors and global trends of bladder cancer in the 7MM( US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of bladder cancer segmented by sex, age( beginning at 15 years and ending at = 75 years), and cancer stage at diagnosis( stage 0, stage I, stage II, stage III, and stage IV), in addition to five-year diagnosed prevalent cases in these seven markets.